Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.
暂无分享,去创建一个
M. Pfisterer | S. von Felten | J. Müller-Brand | R. Jeger | O. Pfister | U. Keller | M. Zellweger | T. Burkard | F. Eckstein | H. Osterhues | S. Osswald | Michael Maraun | J. Müller-Brand
[1] L. Jaacks,et al. Silent myocardial ischemia detected by single photon emission computed tomography (SPECT) and risk of cardiac events among asymptomatic patients with type 2 diabetes: a meta-analysis of prospective studies. , 2014, Journal of diabetes and its complications.
[2] F. Wolf,et al. Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers , 2016, Clinical Diabetes.
[3] M. Zellweger,et al. Prevalence, extent, and independent predictors of silent myocardial infarction. , 2013, The American journal of medicine.
[4] T. Marwick,et al. Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization. , 2013, Journal of the American College of Cardiology.
[5] J. Hochman,et al. Revascularization for silent ischemia?: another piece of the puzzle. , 2013, Journal of the American College of Cardiology.
[6] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[7] Jennifer Taylor. Third universal definition of myocardial infarction. , 2012, European heart journal.
[8] M. Pfisterer,et al. Coronary artery disease progression late after successful stent implantation. , 2012, Journal of the American College of Cardiology.
[9] M. Zellweger,et al. Diabetes reduces left ventricular ejection fraction--irrespective of presence and extent of coronary artery disease. , 2011, European journal of endocrinology.
[10] V. Rigalleau,et al. Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening , 2011, Trials.
[11] L. Young,et al. Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[12] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.
[13] E. Barrett,et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.
[14] Guido Germano,et al. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.
[15] A. Schoenenberger,et al. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study. , 2007, European heart journal.
[16] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[17] R. Gibbons,et al. Improved Survival in Asymptomatic Diabetic Patients With High-Risk Spect Imaging Treated With Coronary Artery Bypass Grafting , 2005, Circulation.
[18] E. Barrett,et al. Erratum: Detection of Ischemia in Asymptomatic Diabetics (DIAD) investigators: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study (Diabetes Care (2004) 27 (1954-1961)) , 2005 .
[19] E. Barrett,et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.
[20] Daniel S. Berman,et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion spect interpretation , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[21] E. Antman,et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.
[22] E. Antman,et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.
[23] D. Berman,et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? , 2003, Journal of the American College of Cardiology.
[24] M. Rutter,et al. Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. , 2002, Journal of the American College of Cardiology.
[25] The Time Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial , 2001, The Lancet.
[26] M. Pfisterer,et al. Silent coronary artery disease in patients with diabetes mellitus. , 2001, Swiss medical weekly.
[27] Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People With Diabetes: 10–11 February 1998, Miami, Florida , 1998, Diabetes Care.
[28] N. Geller,et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. , 1997, Circulation.
[29] D. Ewing,et al. The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes , 1985, Diabetes Care.
[30] J. Alpert,et al. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .
[31] Bengt Jönsson,et al. [Guidelines on diabetes, pre-diabetes, and cardiovascular diseases]. , 2007, Revista espanola de cardiologia.
[32] Y. Jang,et al. Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .
[33] D. Berman,et al. Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion spect: prognostic value and impact on referral to early catheterization , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.